Jefferies Financial Group Inc. (JEF)
| Market Cap | 10.98B |
| Revenue (ttm) | 7.23B |
| Net Income (ttm) | 646.47M |
| Shares Out | 206.28M |
| EPS (ttm) | 2.92 |
| PE Ratio | 18.39 |
| Forward PE | 13.23 |
| Dividend | $1.60 (3.05%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 2,324,012 |
| Open | 52.09 |
| Previous Close | 52.49 |
| Day's Range | 51.51 - 54.27 |
| 52-Week Range | 39.28 - 82.68 |
| Beta | 1.50 |
| Analysts | Buy |
| Price Target | 71.00 (+33.38%) |
| Earnings Date | Jan 7, 2026 |
About JEF
Jefferies Financial Group Inc. operates as an investment banking and capital markets firm in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Investment Banking and Capital Markets, and Asset Management. It provides investment banking, advisory services with respect to mergers or acquisitions, debt financing, restructurings or recapitalizations, and private capital advisory transactions; underwriting and placement services related to corporate debt, municipal debts, mortgage-backed and asset-bac... [Read more]
Financial Performance
In 2024, Jefferies Financial Group's revenue was $7.01 billion, an increase of 49.15% compared to the previous year's $4.70 billion. Earnings were $669.27 million, an increase of 156.48%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for JEF stock is "Buy." The 12-month stock price target is $71.0, which is an increase of 33.38% from the latest price.
News
Saga Diagnostics to Present at Jefferies Global Healthcare Conference in London
MORRISVILLE, N.C.--(BUSINESS WIRE)-- #JefferiesHealthcare--Presentation will focus on its flagship MRD assay, Pathlight, accompanied by a commercial update following its favorable Medicare coverage.
Vicore to Present at The Jefferies Global Healthcare Conference in London
STOCKHOLM, SE / ACCESS Newswire / November 17, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), t...
JEFFERIES INVESTORS: Jefferies Financial Group Inc. (JEF) is being Investigated for Securities Fraud, Investors are Urged to Contact BFA Law
New York, New York--(Newsfile Corp. - November 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...
Medincell Management to Participate in Fireside Chat at the Jefferies London Healthcare Conference 2025 (London - Nov. 17-20, 2025)
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Christophe Douat, Chief Executive Officer, and Dr. Richard Malamut, Chief Medical Officer, will present Medincell's (Paris:MEDCL) corporate overv...
Keenova to Participate in the Jefferies Global Healthcare Conference in London
DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London on Wed...
Beacon Therapeutics to Participate in the Jefferies Global Healthcare Conference
LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics' or ‘the Company'), a leading clinical-stage biotechnology company with a miss...
AdvanCell to participate in Jefferies Global Healthcare Conference in London
SYDNEY--(BUSINESS WIRE)-- #JefferiesGlobalHealthcareConference--AdvanCell to share positive 212Pb-ADVC001 results and US expansion updates at the Jefferies Global Healthcare Conference in London (17–2...
Aqemia to Participate in the Jefferies Global Healthcare Conference 2025
LONDON--(BUSINESS WIRE)--Aqemia, a pioneering TechBio company combining generative AI and quantum-inspired physics to invent drugs, announces that Maximilien Levesque, CEO and co-founder, and Théa Vu-...
Autobahn Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced tha...
JEF STOCK NOTICE: Jefferies Financial Group Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law
New York, New York--(Newsfile Corp. - November 10, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...
JEFFERIES INVESTIGATION: Jefferies Financial Group Inc. (NYSE:JEF) Investors with Losses are Notified of the Pending Securities Fraud Investigation – Contact BFA Law
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...
Secura Bio to Participate in the Jefferies Global Healthcare Conference in London
BERKELEY HEIGHTS, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc. (www.securabio.com), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announ...
JEF INVESTOR REMINDER: Jefferies Financial Group Inc. Investors may have been Affected by Fraud -- Contact BFA Law if You Suffered Losses
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...
JEFFERIES INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Urges Jefferies Stockholders to Contact the Firm Regarding their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jefferies (JEF) To Contact Him Directly To Discuss Their Options If you purchased or acquir...
JEFFERIES INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation into Jefferies Financial Group Inc. on Behalf of Jefferies Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jefferies (JEF) To Contact Him Directly To Discuss Their Options If you purchased or acquir...
Laxxon Medical to Attend BIO-Europe and Jefferies Healthcare Conference World Premier Life Science Partnering Events
NEW YORK--(BUSINESS WIRE)--Laxxon announces attendance at BIO-Europe and Jefferies Healthcare Conference.
JEF INVESTIGATION: Investigation Launched into Jefferies Financial Group Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Firm - RGRD
SAN DIEGO, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Jefferies Financial Group Inc...
JEF INVESTORS: Jefferies Financial Group Inc. Hit with Securities Fraud Investigation after Stock Plummets 8% -- Investors Urged to Contact BFA Law
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital f...
Jefferies Financial Group, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Jefferies Financial Group, Inc., ("Jefferies" or the "Company") (NYSE: JEF) investors that the firm has initiated an investi...
Jefferies Financial Group Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - JEF
LOS ANGELES , Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Jefferies Financial Group Inc. ("Jefferies" or "the Company") (NYSE: J...
JEF Investors Have Opportunity to Join Jefferies Financial Group Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES , Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Jefferies Financial ...
JEF STOCK NOTICE: Jefferies Financial Group Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...
Smarsh Announces Expansion of Relationship with Jefferies
PORTLAND, Ore.--(BUSINESS WIRE)--Today, Smarsh announced that Jefferies has selected the company's flagship communications surveillance technology to address the growing challenge of monitoring vast a...
Jefferies Earns Upgrade After Recent Dip, As M&A Momentum Expected To Continue
Jefferies Financial (JEF) is upgraded to a buy from my prior 2 hold ratings, agreeing with today's Wall St consensus, despite a difficult week in the media for banks. M&A and asset management momentum...
RGRD Launches Investigation into Jefferies Financial Group, Inc. and Encourages Investors and Potential Witnesses to Contact Firm
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Jefferies Financial Group Inc...